Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma

TUESDAY, July 9, 2019 — Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.
The drug…
Source: Topamax